Purchases and Sales Made in Q4 2021 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q4 2021. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 28, 2022
Q4 2021
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
BUY
|
- |
86.8K+ 48.07% |
$556K - $966K
|
267K
$486K
|
|
Feb 17, 2022
Q4 2021
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
22.4KNew |
$144K - $250K
|
22.4K
$40.8K
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
11.5K+ 12155.79% |
$74K - $129K
|
11.6K
$21.2K
|
|
Feb 14, 2022
Q4 2021
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
11.3KNew |
$72.3K - $126K
|
11.3K
$20.5K
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
2.19K+ 7.16% |
$14K - $24.3K
|
32.7K
$59.5K
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
94+ 5.37% |
$603 - $1.05K
|
1.85K
$3.36K
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Jan 28, 2022
Q4 2021
|
Ironwood Financial, LLC
|
SELL
|
- |
-7Closed |
$44.9 - $77.9
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-49Closed |
$314 - $545
|
0
$0
|
|
Jan 14, 2022
Q4 2021
|
Spire Wealth Management
|
SELL
|
- |
-500Closed |
$3.21K - $5.57K
|
0
$0
|
|
Feb 11, 2022
Q4 2021
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-2K- 14.57% |
$12.8K - $22.3K
|
11.7K
$21.4K
|
|
Feb 14, 2022
Q4 2021
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-14.8K- 34.07% |
$94.9K - $165K
|
28.7K
$52.1K
|
|
Feb 14, 2022
Q4 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-20K- 7.01% |
$128K - $223K
|
265K
$483K
|